Form 4: Alignment Healthcare Director Konowiecki Receives Restricted Stock Units

Director Joseph S. Konowiecki of Alignment Healthcare, Inc. was granted 12,903 restricted stock units on May 7, 2025, which will vest on March 13, 2026, subject to continued service on the Board.

Summary

• Joseph S. Konowiecki, a director of Alignment Healthcare, Inc., received 12,903 restricted stock units on May 7, 2025.
• Each restricted stock unit represents the right to receive one share of Alignment Healthcare's common stock.
• The restricted stock units will vest on March 13, 2026, contingent upon Konowiecki's continued service as a member of the Board of Directors.
• Konowiecki has elected to defer receipt of the underlying shares for three years, or until separation of service or a change of control of the Company, if earlier.
• Following the transaction, Konowiecki directly owns 1,177,049 shares of Alignment Healthcare common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock units is a common practice and generally viewed as a positive sign of aligning management interests with shareholders. There are no overtly negative aspects to the announcement.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• Konowiecki's continued service on the board is incentivized by the vesting schedule.

Risks

• The vesting of the restricted stock units is contingent upon Konowiecki's continued service, creating a potential risk if he ceases to serve on the board before March 13, 2026.

Future Outlook

Konowiecki has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).

Industry Context

This is a standard practice for incentivizing and retaining board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice among publicly traded companies to align their interests with shareholders.
• The vesting schedule of these units, typically over a period of one to three years, is also standard practice.
• Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize similar equity-based compensation for their board members.

Stakeholder Impact

• Shareholders may view this as a positive sign, aligning the director's interests with the company's long-term success.
• Employees are unlikely to be directly impacted by this transaction.

Key Dates

Keywords

restricted stock units, Alignment Healthcare, director, Konowiecki, beneficial ownership, Form 4, ALHC, vesting